Milk and dairy products in cancer prevention: Focus on bovine lactoferrin

Mutation Research - Reviews in Mutation Research

Volumn 462, Issue 2-3, 2000, Pages 227-233

  Tsuda, Hiroyuki ^a   Sekine, Kazunori ^a   Ushida, Yoshihiko ^a   Kuhara, Tetsuya ^a   Takasuka, Nobuo ^a   Iigo, Masaaki ^a   Han, Beom Seok ^a   Moore, Malcolm A ^a  

^a NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

Author keywords

Bovine lactoferrin; Carcinogenesis; Colon; Preventive agents; Rat

Indexed keywords

AZOXYMETHANE; CALCIUM; LACTOFERRIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER PREVENTION; CHEMOPROPHYLAXIS; COLON CANCER; COLON CARCINOGENESIS; CONTROLLED STUDY; DAIRY PRODUCT; MALE; MILK; NONHUMAN; PRIORITY JOURNAL; RAT;

ADENOCARCINOMA; ANIMALS; AZOXYMETHANE; CARCINOGENS; COLONIC NEOPLASMS; DAIRY PRODUCTS; DIET; DOSE-RESPONSE RELATIONSHIP, DRUG; INTESTINAL POLYPS; INTESTINES; LACTOFERRIN; MALE; MICE; MICE, INBRED C57BL; MILK; RATS; RATS, INBRED F344;

ANIMALIA; BOVINAE;

EID: 0034029821     PISSN: 13835742     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1383-5742(00)00040-5     Document Type: Article

References (59)

1. World Cancer Research Fund, American Institute for Cancer Research, Food, Nutrition and the Prevention of Cancer, 1997.
2. La Vecchia C., Negri E., D'Avanzo B. Dietary indicators of oral and pharyngeal cancer. Int. J. Epidemiol. 20:1991;39-44.
3. La Vecchia C., Decarli A., Fasoli M. Dietary vitamin A and the risk of intraepithelial and invasive cervical neoplasia. Gynecol. Oncol. 30:1988;187-195.
4. Verrault R., Chu J., Mandelson M., Shy K. A case control study of diet and invasive cervical cancer. Int. J. Cancer. 43:1989;34-38.
5. Ziegler R.G., Brinton L.A., Hamman R.F., Lehman H.F., Levine R.S., Mallin K., Norman S.A., Rosenthal J.F., Trumble A.C., Hoover R.N. Diet and risk of invasive cervical cancer among white women in the United States. Am. J. Epidemiol. 132:1990;432-445.
6. Ziegler R.G., Jones C.J., Brinton L.A. Diet and risk of in situ cervical cancer among white women in the United States. Cancer Causes Control. 2:1991;17-29.
7. Notani P.N., Jayant K. Role of diet in upper aerodigestive tract cancers. Nutr. Cancer. 10:1987;103-113.
8. Tuyns A.J., Riboli E., Doornbos G. Diet and esophageal cancer in Calvados (France). Nutr. Cancer. 9:1987;81-92.
9. Farrow D.C., Davis S. Diet and the risk of pancreatic cancer in men. Am. J. Epidemiol. 132:1990;423-431.
10. La Vecchia C., Negri E., D'Avanzo B. Medical history, diet and pancreatic cancer. Oncology. 47:1990;463-466.
11. Phillips R. Role of life-style and dietary habits in risk of cancer among Seventh-Day Adventists. Cancer Res. 35:1975;3513-3522.
12. Macquart-Moulin G., Riboli E., Cornje J. Case-control study on colorectal cancer and diet in Marseilles. Int. J. Cancer. 38:1986;183-191.
13. Centonze S., Boeing H., Leoci C., Guerra V., Misciagna G. Dietary habits and colorectal cancer in a low-risk area: results from a population-based case-control study in Southern Italy. Nutr. Cancer. 21:1994;233-246.
14. Benito E., Obrador A., Stiggelbout A., Bosch F.X., Mulet M., Munoz N., Kaldor J. A population-based case-control study of colorectal cancer in Majorca: I. Dietary factors. Int. J. Cancer. 45:1990;69-76.
15. Boyd N.F., Martin L.J., Noffel M. A meta-analysis of studies of dietary-fat and breast cancer risk. Br. J. Cancer. 68:1990;627-636.
16. Giovannucci E., Rimm E.B., Colditz G.A., Stampfer M.J., Ascherio A., Chute C.C., Willett W.C. A prospective study of dietary fat and risk of prostate cancer. J. Natl. Cancer Inst. 85:1993;1571-1579.
17. Kesteloot H., Lesaffre E., Joossens J.V. Dietary fat, saturated animal fat, and cancer risk. Prev. Med. 20:1991;226-236.
18. Parodi P.W. Cow's milk fat components as potential anticarcinogenic agents. J. Nutr. 127:1997;1055-1060.
19. Parodi P.W. Conjugated linoleic acid and other anticarcinogenic agents of bovine milk fat. J. Dairy Sci. 82:1999;1339-1349.
20. Ip C., Singh M., Thompson H.J., Scimeca J.A. Conjugated linoleic acid suppresses mammary carcinogenesis and proliferative activity of the mammary gland in the rat. Cancer Res. 54:1994;1212-1215.
21. Ip C., Scimeca J.A., Thompson H. Effect of timing and duration of dietary conjugated linoleic acid on mammary cancer prevention. Nutr. Cancer. 24:1995;241-247.
22. Pence B.C. Role of calcium in colon cancer prevention: experimental and clinical studies. Mutat. Res. 290:1993;87-95.
23. McIntosh G.H. Colon cancer: dietary modifications required for a balanced protective diet. Prev. Med. 22:1993;767-774.
24. Glinghammar B., Venturi M., Rowland I.R., Rafter J.J. Shift from a dairy product-rich to a dairy product-free diet: influence on cytotoxicity and genotoxicity of fecal water-potential risk factors for colon cancer. Am. J. Clin. Nutr. 66:1997;1277-1282.
25. Holt P.R., Atillasoy E.O., Gilman J., Guss J., Moss S.F., Newmark H., Fan K., Yang K., Lipkin M. Modulation of abnormal colonic epithelial cell proliferation and differentiation by low-fat dairy foods: a randomized controlled trial. JAMA. 280:1998;1074-1079.
26. Karagas M.R., Tosteson T.D., Greenberg E.R., Rothstein R.I., Roebuck B.D., Herrin M., Ahnen D. Effects of milk and milk products on rectal mucosal cell proliferation in humans. Cancer Epidemiol., Biomarkers Prev. 7:1998;757-766.
27. Pence B.C., Dunn D.M., Zhao C., Patel V., Hunter S., Landers M. Protective effects of calcium from nonfat dried milk against colon carcinogenesis in rats. Nutr. Cancer. 25:1996;35-45.
28. Giovannucci E. Dietary influences of 1,25(OH)2 vitamin D in relation to prostatecancer: a hypothesis. Cancer Causes Control. 9:1998;567-582. [see comments].
29. Chan J.M., Giovannucci E., Andersson S.O., Yuen J., Adami H.O., Wolk A. Dairy products, calcium, phosphorous, vitamin D, and risk of prostate cancer (Sweden). Cancer Causes Control. 9:1998;559-566.
30. McIntosh G.H., Regester G.O., Le L.R., Royle P.J., Smithers G.W. Dairy proteins protect against dimethylhydrazine-induced intestinal cancers in rats. J. Nutr. 125:1995;809-816.
31. Bounous G., Batist G., Gold P. Whey proteins in cancer prevention. Cancer Lett. 57:1991;91-94.
32. Papenberg R., Bounous G., Fleiszer D., Gold P. Dietary milk proteins inhibit the development of dimethylhydrazine-induced malignancy. Tumour Biol. 11:1990;129-136.
33. Bounous G., Papenburg R., Kongshavn P.A., Gold P., Fleiszer D. Dietary whey protein inhibits the development of dimethylhydrazine induced malignancy. Clin. Invest. Med. 11:1988;213-217.
34. Weisburger J.H., Rivenson A., Garr K., Aliaga C. Tea and milk, inhibit mammary gland and colon carcinogenesis in rats. Cancer Lett. 114:1997;323-327.
35. Abdelali H., Cassand P., Soussotte V., Daubeze M., Bouley C., Narbonne J.F. Effect of dairy products on initiation of precursor lesions of colon cancer on rats. Nutr. Cancer. 24:1995;121-132.
36. Kulkarni N., Reddy B.S. Inhibitory effect on Bifflobacterium longum cultures on the azoxymethane-induced aberrant crypt foci formation and fecal bacterial beta-glucuronidase. Proc. Soc. Exp. Biol. Med. 207:1995;278-283.
37. Hakansson A., Zhivotovsky B., Orrenius S., Sabharwal H., Svanborg C. Apoptosis induced by a human milk protein. Proc. Natl. Acad. Sci., U.S.A. 92:1995;8064-8068.
38. Lonnerdal B., Iyer S. Lactoferrin: molecular structure and biological function. Annu. Rev. Nutr. 15:1995;93-110.
39. Nishiya K., Horwitz D.A. Contrasting effects of lactoferrin on human lymphocyte and monocyte natural killer activity and antibody-dependent cell-mediated cytotoxicity. J. Immunol. 129:1982;2519-2523.
40. Gahr M., Speer C.P., Damerau B., Sawatzki G. Influence of lactoferrin on the function of human polymorphonuclear leukocytes and monocytes. J. Leukocyte Biol. 49:1991;427-433.
41. Sawatzki G., Rich I.N. Lactoferrin stimulates colony stimulating factor production in vitro and in vivo. Blood Cells. 15:1989;371-385.
42. Shau H., Kim A., Golub S.H. Modulation of natural killer and lymphokine-activated killer cell cytotoxicity by lactoferrin. J. Leukocyte Biol. 51:1992;343-349.
43. McCormick J.A., Markey G.M., Morris T.C. Lactoferrin-inducible monocyte cytotoxicity for K562 cells and decay of natural killer lymphocyte cytotoxicity. Clin. Exp. Immunol. 83:1991;154-156.
44. Levay P.F., Viljoen M. Lactoferrin: a general review. Haematologica. 80:1995;252-267.
45. Bezault J., Bhimani J., Wiprovnick P., Furmanski P. Human lactoferrin inhibits growth of solid tumors and development of experimental metastases in mice. Cancer Res. 54:1994;2310-2312.
46. Farley J., Loup D., Nelson M., Mitchell A., Esplund G., Macri C., Harrison C., Gray K. Neoplastic transformation of the endocervix associated with down regulation of lactoferrin expression. Mol. Carcinog. 20:1997;240-250.
47. Sekine K., Watanabe E., Nakamura J., Takasuka N., Kim D.J., Asamoto M., Krutovskikh V., Baba T.H., Ota T., Moore M.A., Masuda M., Sugimoto H., Nishino H., Kakizoe T., Tusda H. Inhibition of azoxymethane-initiated colon tumor by bovine lactoferrin administration in F344 rats. Jpn. J. Cancer Res. 88:1997;523-526.
48. Sekine K., Ushida Y., Kuhara T., Iigo M., Baba-Toriyama H., Moore M.A., Murakoshi M., Satomi Y., Nishino H., Kakizoe T., Tsuda H. Inhibition of initiation and early stage development of aberrant crypt foci and enhanced natural killer activity in male rats administered bovine lactoferrin concomitantly with azoxymethane. Cancer Lett. 121:1997;211-216.
49. Min mouse model by the nonsteroidal anti-inflammatory drug piroxicam. Cancer Res. 56:1996;710-714.
50. Tonelli F., Valanzano R., Dolara P. Sulindac therapy of colorectal polyps in familial adenomatous polyposis. Digest. Dis. 12:1994;259-264.
51. Oshima M., Dinchuk J.E., Kargman S.L., Oshima H., Hancock B., Kwong E., Trzaskos J.M., Evans J.F., Taketo M.M. Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2). Cell. 87:1996;803-809.
52. Britigan B.E., Serody J.S., Cohen M.S. The role of lactoferrin as an anti-inflammatory molecule. Adv. Exp. Med. Biol. 357:1994;143-156.
53. Elverfors J., Motas C. Anti-inflammatory capacities of human milk: lactoferrin and secretary IgA inhibit endotoxin-induced cytokine release. Adv. Exp. Med. Biol. 371A:1995;669-672.
54. Brock J. Lactoferrin: a multifunctional immunoregulatory protein? Immunol. Today. 16:1995;417-419.
55. Yoo Y.C., Watanabe S., Watanabe R., Hata K., Shimazaki K., Azuma I. Bovine lactoferrin and lactoferricin, a peptide derived from bovine lactoferrin, inhibit tumor metastasis in mice. Jpn. J. Cancer Res. 88:1997;184-190.
56. Iigo M., Kuhara T., Ushida Y., Sekine K., Moore M.A., Tsuda H. Inhibitory effects of bovine lactoferrin on colon carcinoma 26 lung metastasis in mice. Clin. Exp. Metastasis. 17:1999;35-40.
57. Tanaka T., Kawabata K., Kohno H., Honjo S., Murakami M., Ota T., Tsuda H. Chemopreventive effect of bovine lactoferrin on 4-nitroquinioline 1-oxide-induced tongue carcinogenesis in male F344 rats. Jpn. J. Cancer Res. 91:2000;. in press.
58. Masuda C., Wanibuchi H., Sekine K., Yano Y., Otani S., Kishimoto T., Tsuda H., Fukushima S. Chemopreventive effect of bovine lactoferrin on N-butyl-N-(4-hydroxybutyl)nitrosamine-induced bladder carcinogenesis. Jpn. J. Cancer Res. 91:2000;. in press.
59. Min mouse. Cancer Lett. 134:1998;141-145.